Variam Ullas Jeankumar

779 total citations
25 papers, 628 citations indexed

About

Variam Ullas Jeankumar is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Variam Ullas Jeankumar has authored 25 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Variam Ullas Jeankumar's work include Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Variam Ullas Jeankumar is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Variam Ullas Jeankumar collaborates with scholars based in India, Russia and Sweden. Variam Ullas Jeankumar's co-authors include Dharmarajan Sriram, Perumal Yogeeswari, Janupally Renuka, Jonnalagadda Padma Sridevi, Shalini Saxena, Priyanka Suryadevara, Mallika Alvala, Vijay Soni, R. Reshma and Pushkar Kulkarni and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Variam Ullas Jeankumar

25 papers receiving 620 citations

Peers

Variam Ullas Jeankumar
Variam Ullas Jeankumar
Citations per year, relative to Variam Ullas Jeankumar Variam Ullas Jeankumar (= 1×) peers Shalini Saxena

Countries citing papers authored by Variam Ullas Jeankumar

Since Specialization
Citations

This map shows the geographic impact of Variam Ullas Jeankumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Variam Ullas Jeankumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Variam Ullas Jeankumar more than expected).

Fields of papers citing papers by Variam Ullas Jeankumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Variam Ullas Jeankumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Variam Ullas Jeankumar. The network helps show where Variam Ullas Jeankumar may publish in the future.

Co-authorship network of co-authors of Variam Ullas Jeankumar

This figure shows the co-authorship network connecting the top 25 collaborators of Variam Ullas Jeankumar. A scholar is included among the top collaborators of Variam Ullas Jeankumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Variam Ullas Jeankumar. Variam Ullas Jeankumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reshma, R., Variam Ullas Jeankumar, Nidhi Kapoor, et al.. (2017). Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. Bioorganic & Medicinal Chemistry. 25(10). 2761–2771. 23 indexed citations
2.
Jeankumar, Variam Ullas, R. Reshma, Rahul Vats, et al.. (2016). Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. European Journal of Medicinal Chemistry. 122. 216–231. 27 indexed citations
3.
Reshma, R., et al.. (2016). Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors. Bioorganic & Medicinal Chemistry. 24(18). 4499–4508. 11 indexed citations
4.
Raut, Rajendra, Poornima Tyagi, Ira Khanna, et al.. (2015). A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virology Journal. 12(1). 16–16. 50 indexed citations
5.
Jeankumar, Variam Ullas, T. Haikarainen, Jarkko Koivunen, et al.. (2015). Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics. Bioorganic & Medicinal Chemistry. 23(15). 4139–4149. 22 indexed citations
6.
Devi, Parthiban Brindha, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, et al.. (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis. 95(6). 786–794. 13 indexed citations
7.
Sridevi, Jonnalagadda Padma, Variam Ullas Jeankumar, Shalini Saxena, et al.. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry. 86. 613–627. 26 indexed citations
8.
Renuka, Janupally, Variam Ullas Jeankumar, Vijay Soni, et al.. (2014). Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus. Bioorganic & Medicinal Chemistry. 22(21). 5970–5987. 18 indexed citations
9.
Konduri, Srihari, Janupally Renuka, Variam Ullas Jeankumar, et al.. (2014). An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition. Bioorganic & Medicinal Chemistry. 22(23). 6552–6563. 38 indexed citations
10.
Jeankumar, Variam Ullas, Janupally Renuka, Priyanka Suryadevara, et al.. (2014). Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: Hit to lead optimization of a novel class of thiazole inhibitors. Bioorganic & Medicinal Chemistry. 23(3). 588–601. 22 indexed citations
11.
Jeankumar, Variam Ullas, Janupally Renuka, Shalini Saxena, et al.. (2014). Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure‐Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues. ChemMedChem. 9(8). 1850–1859. 12 indexed citations
12.
Jeankumar, Variam Ullas, R. Reshma, Janupally Renuka, et al.. (2014). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry. 13(8). 2423–2431. 24 indexed citations
13.
Renuka, Janupally, et al.. (2014). Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: Pharmacophore mapping from known antibacterial leads. European Journal of Medicinal Chemistry. 85. 593–604. 9 indexed citations
14.
Renuka, Janupally, Srihari Konduri, Variam Ullas Jeankumar, et al.. (2014). Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 22(17). 4924–4934. 46 indexed citations
15.
Sridevi, Jonnalagadda Padma, Variam Ullas Jeankumar, Shalini Saxena, et al.. (2014). Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry. 22(21). 6134–6145. 9 indexed citations
16.
Jeankumar, Variam Ullas, Janupally Renuka, Vijay Soni, et al.. (2013). Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial leads. International Journal of Antimicrobial Agents. 43(3). 269–278. 32 indexed citations
17.
Jeankumar, Variam Ullas, Janupally Renuka, Vijay Soni, et al.. (2013). Thiazole–aminopiperidine hybrid analogues: Design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. European Journal of Medicinal Chemistry. 70. 143–153. 58 indexed citations
18.
Jeankumar, Variam Ullas, et al.. (2012). Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation. Bioorganic & Medicinal Chemistry Letters. 22(8). 2764–2767. 25 indexed citations
19.
Alvala, Mallika, Shubhmita Bhatnagar, Ravi Alvala, et al.. (2012). Novel acridinedione derivatives: Design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies. Bioorganic & Medicinal Chemistry Letters. 22(9). 3256–3260. 35 indexed citations
20.
Sriram, Dharmarajan, et al.. (2011). Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(18). 5149–5154. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026